Age Related Macular Degeneration Market Snapshot
Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally. Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.
This MRFR study offers a vivid view of the global age-related macular degeneration AMD market. The study includes an in-depth analysis of macro and micro-economic factors likely to influence the market during the forecast period (2018-2023). It further summarizes the key market opportunities and trends.
Get Exclusive Sample Copy of Age Related Macular Degeneration Market Report spread across 220 Premium Pages, Top 10 Companies Profile and Supported with 96 Tables and Figures is Now Available Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5736 .
Value, Market Share, Player Analysis, value chain analysis, Porter’s five forces model, demand & supply, gap analysis, investment opportunities analysis, pricing analysis, technological trends, country level break down for type, stages, age group, diagnosis & treatment, route of administration, and end-user.
Some of the key players in this market are F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals, and others.
Market Research Future’s market perspectives bring forth a great deal of clarity to the current market scenarios and how the competitors are strategizing in the present set up. MRFR’s reports have an intrinsic capability to cover all aspects relevant to forming a knowledgeable view of any given market. The use of primary and secondary research inputs increases the efficacy of the reports in achieving the main objective of delivering an unbiased market forecast. The clients, through our reports gain access to information that can transform their business strategies, significantly helping them to capture a greater portion of the market. The best strategies for growth in the market are highlighted upon so as to develop in the market intensively. The top up and bottom down approaches employed are useful in uncovering the trends that will be shaping the market in the forecast period.
- Market Denomination- USD Million
- Base year- 2017
- Forecast Period- From 2018 to 2023
Age Related Macular Degeneration Market Bulleted Segmentation
- Wet Age-Related Macular Degeneration (Wet AMD)/Neovascular
- Dry Age-Related Macular Degeneration (Dry AMD)/Non-Neovascular
- Intermediate Age-Related Macular Degeneration (AMD)
- Early Age-Related Macular Degeneration (AMD)
- Late Age-Related Macular Degeneration (AMD)
- >75 years
- >60 years
- >40 years
Diagnosis & Treatment
Route of Administration
- Hospitals & Clinics
- Diagnostic Centers
- Academic Research Institutes
- North America; The U.S., and Canada
- Europe; Germany, the UK, France, Spain, Italy, and Rest of Europe
- Asia Pacific (APAC); China, Japan, India and Rest of Asia Pacific
- The Middle East & Africa (MEA)
- South America
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/5736 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar